期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

哌甲酯渗透泵控释剂的特征及其治疗注意缺陷多动障碍的疗效 被引量：1

下载PDF
导出
摘要 盐酸哌甲酯渗透泵控释剂是近来进入国内临床使用的长效中枢兴奋剂,由于其具有独特的药物制剂形式,理论上具有持续稳定释放药物以提高治疗效果的作用。本文将从药物的基本特征、药物的疗效评价、药物的起效时间和作用时间、药物的副作用以及其在共病上的使用等方面做综述。
作者 江文庆 杜亚松
机构地区 上海市精神卫生中心儿童病房
出处 《中国儿童保健杂志》 CAS 2007年第2期167-169,共3页 Chinese Journal of Child Health Care
关键词 哌甲酯 注意缺陷多动障碍 中枢兴奋剂
分类号 R179 [医药卫生—妇幼卫生保健]
  • 相关文献

参考文献15

  • 1Kuteher S, Aman M, Sarah J. International consensus statement on attention-deficit/hyperactivity disorder (ADHD)and disruptive behavior disorders (DBDs) : clinical implications and treatment practice suggestions[J]. Eur Neuropsychophamacology, 2004,14 : 11-28.
  • 2Hoare P, Remschmidt H, Medori R. 12-month Efficacy and safety of OROS MPH in children and adolescents with attention-deficit/hyperactivity disorder switched from MPH[J].Eur Child Adolesc Psychiatry, 2005,14 : 305-309.
  • 3Tamhne R, Thompson M, Tinline C, et al. Symptom control in children and adolescents with attention-deficit/hyperactivity disorder on switching from immediate-release MPH to OROS MPH results of a 3-week open-label study[J]. Eur Child Adolesc Psychiatry, 2005,14:297-304.
  • 4Steele M, Weiss M, Swanson J. A randomized, controlled, effectiveness trial of OROS-methylphenidate compared to usual care with immediate-release methylphenidate in attention deficit hyperactivity disorder [J]. Can J Clin Pharmacol,2006,13:50-62.
  • 5Marcus SC,Wan GJ,Kemner JE, et al . Continuity of methylphenidate treatment for attention-deficit/hyperactivity disorder[J]. Arch Pediatr Adolese Med,2005,159 : 875-876.
  • 6Starr HL, Kemner J. Multieenter, randomized, open-label study of OROS methylphenidate versus atomoxetine: treatment outcomes in African-American children with ADHD[J]. J Nat Med Assoeiation,2005,97(S) :11-16.
  • 7钱秋谨,王玉凤,杜亚松,郑毅,王民洁,姚晨,杨莉,程嘉,巫雪莹.盐酸哌甲酯控释片治疗注意缺陷多动障碍的多中心、随机、双盲、交叉对照研究[J].中华精神科杂志,2005,38(2):90-94. 被引量：17
  • 8Sonuga-Barke EJ ,Swanson JM, Coghill D, et al. Efficacy of two once-daily methylphenidate formulations compared across dose levels at different times of the day: preliminary indications from a secondary analysis of the COMACS study data[J]. BMC Psychiatry, 2004,4:28-30.
  • 9Hazell P. Review of new compounds available in Australia for the treatment of attention-deficit hyperactivity disorder[J]. Aus Psychi,2004,12 : 369-375.
  • 10Cox D, Lawrencemerkel R. Impact of methylphenidate delivery profiles on driving performance of adolescents with attention-deficit/hyperactivity disorder: A pilot studyJ[ J],Childadolesc Psychiatry, 2004,43 : 3-6.

二级参考文献13

  • 1Elia J. Drug treatment for hyperactive children:therapeutic guidelines. Drugs, 1993, 46:863-871.
  • 2Greenhill LL. Pharmacologic treatment of attention deficit hyperactivity disorder. Psychiatr Clin North Am, 1992, 15:1-27.
  • 3Spencer T, Biederman J, Wilens T, et al. Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle. J Am Acad Child Adolesc Psychiatry, 1996, 35:409-432.
  • 4Gadow KD, Nolan EE, Sverd J, et al. Methylphenidate in aggressive-hyperactive boys: I.effects on peer aggression in public school settings. J Am Acad Child Adolesc Psychiatry, 1990, 29:710-718.
  • 5Hoffman BB, Lefkowitz RJ. Catecholamines, sympathetic drugs, and adrenergic receptor antagonists. In: Hardman J, Limbird L, Molinoff P, eds. Goodman and gilman's the pharmacological basis of therapeutics. 9th ed. New York: MacMillan Publishing, 1996. 199-248.
  • 6Wolraich ML, Doffing MA.Pharmacokinetic considerations in the treatment of attention-deficit hyperactivity disorder with methylphenidate. CNS Drugs, 2004, 18:243-250.
  • 7Gonzalez MA, Pentikis HS, Anderl N, et al. Methylphenidate bioavailability from two extended-release formulations. Int J Clin Pharmacol Ther, 2002, 40:175-184.
  • 8Markowitz JS, Straughn AB, Patrick KS, et al. Pharmacokinetics of methylphenidate after oral administration of two modified-release formulations in healthy adults. Clin Pharmacokinet, 2003, 42:393-401.
  • 9Swanson JM, Wigal SB, Wigal T, et al. A comparison of once-daily extended-release methylphenidate formulations in children with attention-deficit/hyperactivity disorder in the laboratory school (the Comacs Study). Pediatrics, 2004,113(3 Pt 1):e206-216.
  • 10Lopez F, Silva R, Pestreich L, et al. Comparative efficacy of two once daily methylphenidate formulations (Ritalin LA and Concerta) and placebo in children with attention deficit hyperactivity disorder across the school day. Paediatr Drugs, 2003, 5:545-555.

共引文献16

同被引文献15

  • 1Biederman J,Faraone SV,Spencer TJ,et al.Functional impairments in adults with self-reports of diagnosed ADHD:A controlled study of 1001 adults in the community[l].J Clin Psychiatry,2006,67 (4):524-540.
  • 2Fischer M.Parenting stress and the child with attention deficit hyperactivity disorder[J].J Clin Child Psychol,1990,19 (4):337-346.
  • 3Mash EJ,Johnston C.Determants of parenting stress:Illustrations from families of hyperactive children and families of physically abused children[J].J Clin Child Psychol,1990,19 (4):313-328.
  • 4American Psychiatric Association.Diagnosis and Statistical Manual of Mental Disorders[M].4th ed.Washington DC:The American Psychiatric Association,1994:78-85.
  • 5Yeh CH,Chen ML,Li W,et al.The Chinese version of the Parenting Stress Index:a psychometric study[J].Acta Paediatr,2001,90 (12):1470-1477.
  • 6Abidin RR.Parenting stress index Professional Manual (Third Edition)[M].Lutz,FL:Psychological Assessment Resources,1995:3-51.
  • 7WFMH.ADHD impacts entire family:parents urge for faster diagnosis[C].Berlin:16th World Congress of the International Association for Child and Adolescent Psychiatry and Allied Professions,2004:75.
  • 8Treacy L,Tripp G,Baird A.Parent Stress Management Training for Attention-Deficit/Hyperactivity Disorder[J].Behav Ther,2005,36 (3):223-233.
  • 9Anastopoulos AD,Guevremont DC,Shelton TL,et al.Parenting Stress Among Families of Children with Attention Deficit Hyperactivity Disorder[J].J Ahnorm Child Psychol,1992,20 (5):503-520.
  • 10Steele M,Jensen IS,Quinn ME Remission Versus Response as the Goal of Therapy in ADHD:A New Standard for the Field?[J].Clin Ther,2006,28 (11):1892-1908.

引证文献1

二级引证文献8

中国儿童保健杂志
2007年 第2期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部